Thursday, March 5, 2020
Morning
07:00 a.m. - 12:15 p.m.
Location: Peninsula 1-3
Annual Pre-Course (Separate Registration Required)
Moderator: Tami Rowen, MD, MS, FACOG, IF (USA)
07:00 a.m. - 07:30 a.m.
Location: Foyer
Breakfast - Pre-Course Registrants Only
07:30 a.m. - 07:40 a.m.
Location: Peninsula 1-3
Welcome and Introduction
Moderator: Tami Rowen, MD, MS, FACOG, IF (USA)
07:40 a.m. - 09:10 a.m.
Location: Peninsula 1-3
Identification of Sexual Health Problems
Moderator: Tami Rowen, MD, MS, FACOG, IF (USA)
07:40 a.m. - 08:00 a.m.
Update on Epidemiology and Nomenclature
Speaker: Sharon Parish, MD, IF, NCMP (USA)
08:00 a.m. - 08:25 a.m.
Sexual Health Interview
Speaker: Sharon Parish, MD, IF, NCMP (USA)
08:25 a.m. - 08:40 a.m.
Physical Exam
Speaker: Tami Rowen, MD, MS, FACOG, IF (USA)
08:40 a.m. - 09:10 a.m.
Testing Procedures: Hormonal, Vascular, Neurologic
Speaker: Rachel Rubin, MD, IF (USA)
09:10 a.m. - 09:25 a.m.
Location: Foyer
Coffee Break
09:25 a.m. - 10:15 a.m.
Location: Peninsula 1-3
HSDD
Moderator: Tami Rowen, MD, MS, FACOG, IF (USA)
09:25 a.m. - 09:50 a.m.
ISSWSH Processes of Care
Speaker: Sharon Parish, MD, IF, NCMP (USA)
09:50 a.m. - 10:15 a.m.
Non-Hormonal Pharmacological Treatments
Speaker: Rachel Rubin, MD, IF (USA)
10:15 a.m. - 10:55 a.m.
Location: Peninsula 1-3
Hormones
Moderator: Tami Rowen, MD, MS, FACOG, IF (USA)
10:15 a.m. - 10:40 a.m.
Hormonal Treatment: Estrogens and Progestogens
Speaker: Tami Rowen, MD, MS, FACOG, IF (USA)
10:40 a.m. - 10:55 a.m.
Hormonal Treatment: Androgens
Speaker: Sharon Parish, MD, IF, NCMP (USA)
10:55 a.m. - 11:50 a.m.
Location: Peninsula 1-3
Sexual Pain
Moderator: Tami Rowen, MD, MS, FACOG, IF (USA)
10:55 a.m. - 11:15 a.m.
Painful Intercourse: Causes, Evaluation and Treatment
Speaker: Rachel Rubin, MD, IF (USA)
11:15 a.m. - 11:35 a.m.
Vestibulodynia: Diagnosis and Treatment
Speaker: Rachel Rubin, MD, IF (USA)
11:35 a.m. - 11:50 a.m.
Treatment Options for GSM
Speaker: Tami Rowen, MD, MS, FACOG, IF (USA)
11:50 a.m. - 12:00 p.m.
Location: Peninsula 1-3
Q&A
Moderator: Tami Rowen, MD, MS, FACOG, IF (USA)
12:00 p.m. - 12:15 p.m.
Location: Foyer
Lunch - Pre-Course Registrants Only
Afternoon
12:15 p.m. - 12:30 p.m.
Location: Peninsula 4
Opening Ceremony
Welcome Comments
Speaker: Rose Hartzell-Cushanick, PhD, EdS, CHES, LMFT, IF (USA)
12:30 p.m. - 01:30 p.m.
Location: Peninsula 4
Sandra Leiblum ISSWSH Presidential Lecture
Moderator: Rose Hartzell-Cushanick, PhD, EdS, CHES, LMFT, IF (USA)
How the US Government and The Media Conspired to Convince Women That Menopausal Hormone Therapy Was Dangerous
Speaker: James Simon, MD, CCD, NCMP, FACOG, IF (USA)
01:30 p.m. - 03:00 p.m.
Location: Peninsula 4
Symposium 1 - Caring for Transgender Patients: What Every Provider Needs to Know
Moderators: Heather Howard, PhD, MPH, MBA, AASECT-CSC, AASECT-CSE, IF (USA) & Tami Rowen, MD, MS, FACOG, IF (USA)
01:30 p.m. - 02:00 p.m.
Caring for the Whole Person: Addressing Social, Psychological, Relational, and Cultural issues for Gender Diverse Patients
Speaker: Laura Jacobs, LCSW-R (USA)
02:00 p.m. - 02:20 p.m.
Physical Therapy in Transgender Health Care
Speaker: Hollis Herman, DPT, OCS, WCS, BCB-PMD, AASECT, PRPC, IF (USA)
02:20 p.m. - 03:00 p.m.
Best Practices in Medical Treatment for Transgender Patients: Hormone Therapy, Pre- and Post-operative Care, Gender-confirming Surgeries, and Co-occurring Medical Concerns
Speaker: Tami Rowen, MD, MS, FACOG, IF (USA)
03:00 p.m. - 03:30 p.m.
Location: Canaveral
Coffee Break
03:00 p.m. - 03:30 p.m.
Location: Foyer
New Member/New Attendee Meet-Up
03:30 p.m. - 04:30 p.m.
Location: Peninsula 4
State of the Art Session 1 - Lessons From the Sex Wars: Do Good Values Make Bad Sexual Science?
Moderators: Irwin Goldstein, MD, IF (USA) & James Simon, MD, CCD, NCMP, FACOG, IF (USA)
Speaker: William Fisher, PhD (Canada)
04:30 p.m. - 06:00 p.m.
Location: Peninsula 1-3
Instructional Course 1 - Vulvar Dermatoses
Speakers: Andrew Goldstein, MD, IF, FACOG (USA) & Lynette Margesson, MD (USA)
04:30 p.m. - 06:10 p.m.
Location: Peninsula 4
Research Podium Session 1 - Chronic Illness, Pain and New Technologies
Moderators: Joshua Gonzalez, MD (USA) & Paul Yong, MD, PhD, FRCSC (Canada)
04:30 p.m. - 04:40 p.m.
A Novel Collaboration for Successful Management of Genito-Pelvic Dysesthesias Mediated by Radiculopathy of Sacral Spinal Nerve Roots Within the Cauda Equina: Four-Year Experience (#001)
Speaker: Choll Kim, MD, PhD (USA)
04:40 p.m. - 04:50 p.m.
Sexual Dysfunction in Relation to Tumor Type, Location, and Treatment in Brain Cancer Patients (#002)
Speaker: Maria Boccia (USA)
04:50 p.m. - 05:00 p.m.
Sleeping Beauty Syndrome: A Rare Sleep Sexuality Disorder (#003)
Speaker: Blake Zwerling (USA)
05:00 p.m. - 05:10 p.m.
Safety and Efficacy of CO2 Fractional Laser Therapy in Women with Vestibulodynia (#004)
Speaker: Sue Goldstein, BA, CCRC, AASECT-CSE, IF (USA)
05:10 p.m. - 05:20 p.m.
Clitorodynia: The Unexplored Subtype of Vulvodynia. Preliminary Results of a Cross-sectional Controlled Study
(#005)
Speaker: Leen Aerts (Switzerland)
05:20 p.m. - 05:30 p.m.
Sexual Function in Women after Treatment for Colorectal Cancer and Anal Cancer (#006)
Speaker: Marissa Savoie (USA)
05:30 p.m. - 05:40 p.m.
The Bionic Breast Project: Developing a Measure of Breast Function in Women With and Without a History of Breast Cancer using PROMIS Standards (#007)
Speaker: Emily Abramsohn (USA)
05:40 p.m. - 05:50 p.m.
A Qualitative Exploration of Sexual Quality of Life, Medication Adherence, and Patient-provider Sexual Communication Among Black Breast Cancer Survivors with Sexual Trauma Histories (#008)
Speaker: Janeane Anderson (USA)
05:50 p.m. - 06:00 p.m.
Retrospective Chart Review of Treatment Outcome Following Low-Intensity Shockwave Therapy for the Treatment of Vestibulodynia with Urogold 100™ MTS (#009)
Speaker: Jessica Yih (USA)
06:00 p.m. - 06:10 p.m.
The Moderation Effect of Couple-level Sexual Satisfaction on Physiological Synchrony During Conversation-based Tasks (#010)
Speaker: Bridget Freihart (USA)
Evening
06:00 p.m. - 07:30 p.m.
Location: Canaveral
Welcome Reception
Friday, March 6, 2020
Morning
08:00 a.m. - 09:00 a.m.
Location: Peninsula 4
State of the Art Session 2 - A Reflection on Genital Self-image: Epidemiological and Surgical Perspectives of a Complex Issue
Moderators: Nicole Cirino, MD (USA) & Rose Hartzell-Cushanick, PhD, EdS, CHES, LMFT, IF (USA)
Speakers: Michael Goodman, MD, FACOG, NCMP, IF (USA) & Tami Rowen, MD, MS, FACOG, IF (USA)
09:00 a.m. - 10:30 a.m.
Location: Peninsula 1-3
Instructional Course 2 - Sensate Focus
Speakers: Constance Avery-Clark, PhD (USA) & Linda Weiner, MSW (USA)
09:00 a.m. - 10:40 a.m.
Location: Peninsula 4
Research Podium Session 2 - Clinical Trials in FSD
Moderators: Anita Clayton, MD, IF (USA) & Noel Kim, PhD, IF (USA)
09:00 a.m. - 09:10 a.m.
Correlation Between Validated Instruments Used in the RECONNECT Studies (#011)
Speaker: Sheryl Kingsberg, PhD, IF (USA)
09:10 a.m. - 09:20 a.m.
Bremelanotide Treatment Provided Clinically Meaningful Benefits in Premenopausal Women With Hypoactive Sexual Desire Disorder (#012)
Speaker: Sheryl Kingsberg, PhD, IF (USA)
09:20 a.m. - 09:30 a.m.
The Development and Implementation of a Gynecologic Cancer Survivorship Tool (#013)
Speaker: Jeanne Carter (USA)
09:30 a.m. - 09:40 a.m.
“I Don’t Want to Get Fat, and I Don’t Like Working Out So….” - Perceptions of Contraception Among College-aged Students: Weight Gain vs Protection
(#014)
Speaker: Oluwabunmi Ogungbe (USA)
09:40 a.m. - 09:50 a.m.
The Impact of Incontinence Procedures at the Time of Vaginal Vault Suspension on Pelvic Pain and Dyspareunia: A Study of Sexually Active Women with Post Hysterectomy Prolapse (#015)
Speaker: Veronica Winget (USA)
09:50 a.m. - 10:00 a.m.
Effectiveness of Medications for Female Sexual Dysfunction: Number Needed To Treat (NNT) (#016)
Speaker: Robert Pyke (USA)
10:00 a.m. - 10:10 a.m.
Retrospective Review of Lumbo-Sacral Shockwave Therapy Outcomes for Genito-pelvic Dysesthesia/Persistent Genital Arousal Disorder (#017)
Speaker: Jessica Yih (USA)
10:10 a.m. - 10:20 a.m.
The Impact of Labia Minora Labiaplasty on Patients' Perceptions of Their Genitals (#018)
Speaker: Troy Hailparn (USA)
10:20 a.m. - 10:30 a.m.
Evaluating the Role of Relationship Status in the Sexual Well-being of Women With and Without Histories of Nonconsensual Sexual Experiences (#019)
Speaker: Mackenzie Sears (USA)
10:30 a.m. - 10:40 a.m.
Oral Contraceptive use Influences Subjective and Physiological Sexual Arousal (#020)
Speaker: Ariel Handy (USA)
10:30 a.m. - 11:00 a.m.
Location: Canaveral
Coffee Break
11:00 a.m. - 11:30 a.m.
Location: Peninsula 4
ISSM Lecture
Moderator: Luiz Otavio Torres, MD (Brazil)
Why Do We Have Sex?
Speaker: Annamaria Giraldi, MD, PhD, IF (Denmark)
11:30 a.m. - 12:00 p.m.
Location: Peninsula 4
ESSM Lecture
Moderator: Michal Lew-Starowicz, MD, PhD (Poland)
Pelvic Organ Disorders and Sexual Function
Speaker: Lior Lowenstein, MD, MS, MHA, MBA (Israel)
Afternoon
12:00 p.m. - 01:00 p.m.
Location: Peninsula 4
Lunch and Learn 1 - Alternative Sexual Practices: Polyamory and BDSM
Speakers: Brooke Faught, DNP, WHNP-BC, NCMP, IF (USA) & Susan Kellogg-Spadt, PhD, CRNP, IF (USA)
12:00 p.m. - 01:00 p.m.
Location: Peninsula 1-3
Lunch and Learn 2 - Sexual Health in Muslim, Southeast Asian and Arab Women
Speaker: Sameena Rahman, MD, IF (USA)
01:00 p.m. - 02:00 p.m.
Location: Peninsula 4
State of the Art Session 3 - PGAD: Where are we now?
Moderators: Sharon Parish, MD, IF, NCMP (USA) & Rachel Rubin, MD, IF (USA)
Speakers: Irwin Goldstein, MD, IF (USA) & Choll Kim, MD, PhD (USA)
02:00 p.m. - 02:30 p.m.
Location: Peninsula 4
SSTAR Lecture
Moderator: Rose Hartzell-Cushanick, PhD, EdS, CHES, LMFT, IF (USA)
A Randomized Clinical Trial Comparing a Cognitive-behavioral Couple Intervention and Lidocaine for Women with Provoked Vestibulodynia
Speaker: Sophie Bergeron, PhD (Canada)
02:30 p.m. - 03:00 p.m.
Location: Peninsula 4
Scientific Network on Female Sexual Health and Cancer Lecture
Moderator: Sharon Parish, MD, IF, NCMP (USA)
Sexual Health in Special Cancer Populations
Speaker: Shari Goldfarb, MD (USA)
03:00 p.m. - 03:30 p.m.
Location: Canaveral
Coffee Break
03:30 p.m. - 05:00 p.m.
Location: Peninsula 4
Symposium 2 - Sex: A Body in the Mirror....
Moderator: Nicole Cirino, MD (USA)
03:30 p.m. - 04:00 p.m.
......Unraveling Cardio Metabolic Diseases
Speaker: Elisa Maseroli, MD (Italy)
04:00 p.m. - 04:30 p.m.
......Unravelling Orthopedic Diseases
Speaker: Karen Brandon, DSc, PT (USA)
04:30 p.m. - 05:00 p.m.
......Unraveling Neurological Diseases
Speaker: Mitchell Tepper, PhD, MPH (USA)
05:00 p.m. - 05:45 p.m.
Location: Peninsula 4
Journals Session
Moderator: Irwin Goldstein, MD, IF (USA)
05:00 p.m. - 05:15 p.m.
Journal of Sexual Medicine - Androgen Receptor Polymorphism and Female Sexual Function and Desire
Speaker: Annamaria Giraldi, MD, PhD, IF (Denmark)
05:15 p.m. - 05:30 p.m.
Sexual Medicine Reviews - The Role of Physical Therapy in Sexual Health in Men and Women: Evaluation and Treatment
Speaker: Amy Stein, DPT, BCB-PMD, IF (USA)
05:30 p.m. - 05:45 p.m.
Sexual Medicine - The Relationship between Marijuana Use Prior to Sex and Sexual Function in Women
Speaker: Becky K. Lynn, MD, IF (USA)
Evening
05:45 p.m. - 06:45 p.m.
Location: Peninsula 1-3
ISSWSH Business Meeting (members only)
06:45 p.m. - 07:45 p.m.
Location: Biscayne
Early Career Professionals Mixer (with drinks and food)
Saturday, March 7, 2020
Morning
06:30 a.m. - 08:00 a.m.
Location: Peninsula 4
Special Interest Breakfast - PGAD
07:00 a.m. - 08:00 a.m.
Location: Peninsula 1-3
Special Interest Breakfast - Management of Sexual Pain / Dyspareunia
07:00 a.m. - 07:05 a.m.
Introductions and Review of Progress of the ISSWSH SIG on Sexual Pain/Dyspareunia
07:05 a.m. - 07:30 a.m.
Dysorgasmia Case Presentations and Discussion
07:30 a.m. - 07:45 a.m.
Building a Framework for Diagnosis/Management of Dysorgasmia
07:45 a.m. - 08:00 a.m.
Preparing for a Review Article on Dysorgasmia
07:00 a.m. - 08:00 a.m.
Location: Peninsula 5-7
Special Interest Breakfast - Scientific Network on Female Sexual Health and Cancer
08:00 a.m. - 09:00 a.m.
Location: Peninsula 4
Staying Connected: Using Social Media as a Networking Tool to Enhance Patient Care
Moderator: Becky K. Lynn, MD, IF (USA)
Speakers: Dana Corriel, MD (USA) & Allan Gelbard, Esq. (USA)
09:00 a.m. - 10:30 a.m.
Location: Peninsula 4
Symposium 3 - HSDD
Moderators: Rose Hartzell-Cushanick, PhD, EdS, CHES, LMFT, IF (USA) & Tami Rowen, MD, MS, FACOG, IF (USA)
09:00 a.m. - 09:22 a.m.
FSIAD, Sexual Desire and Arousal
Speaker: Meredith Chivers, PhD, CPsych (Canada)
09:22 a.m. - 09:44 a.m.
ISSWSH Clinical Practice Guideline on the Use of Systemic Testosterone Therapy for HSDD/FSD
Speaker: Sharon Parish, MD, IF, NCMP (USA)
09:44 a.m. - 10:06 a.m.
Basic Science Behind HSDD
Speaker: James Pfaus, PhD, IF (Canada)
10:06 a.m. - 10:28 a.m.
CNS and HSDD
Speaker: Brooke Faught, DNP, WHNP-BC, NCMP, IF (USA)
10:30 a.m. - 11:00 a.m.
Location: Canaveral
Coffee Break
11:00 a.m. - 12:00 p.m.
Location: Peninsula 4
State of the Art Session 4 - Survey on Sexual Fantasies
Moderators: Rose Hartzell-Cushanick, PhD, EdS, CHES, LMFT, IF (USA) & Heather Howard, PhD, MPH, MBA, AASECT-CSC, AASECT-CSE, IF (USA)
Speaker: Justin Lehmiller, PhD (USA)
Afternoon
01:00 p.m. - 02:30 p.m.
Location: Peninsula 1-3
Instructional Course 3 - Neurologic Causes of Sexual Dysfunction
Speakers: Irwin Goldstein, MD, IF (USA); Choll Kim, MD, PhD (USA) & Barry Komisaruk, PhD (USA)
01:00 p.m. - 02:40 p.m.
Location: Peninsula 4
Research Podium Session 3 - Basic and Translational Research
Moderator: Noel Kim, PhD, IF (USA)
01:00 p.m. - 01:10 p.m.
Brain Activity Generated by Self and Partner-Induced Orgasm: Functional MRI Evidence
(#021)
Speaker: Nan Wise (USA)
01:10 p.m. - 01:20 p.m.
Preliminary Efficacy of Sildenafil Cream, 3.6% During Female Sexual Arousal (#022)
Speaker: Sue Goldstein, BA, CCRC, AASECT-CSE, IF (USA)
01:20 p.m. - 01:30 p.m.
Investigation of Sensory Innervation in the Surgical Field of Mid-Urethral Sling and Loop Electrosurgical Excision Procedures in Periurethral and Cervical Tissues Using Immunohistochemistry (#023)
Speaker: Olivia Giovannetti (Canada)
01:30 p.m. - 01:40 p.m.
Estradiol/Progesterone Oral Capsules Improved Vaginal Dryness in Women with Vasomotor Symptoms (VMS) with No Negative Effects on Desire (#024)
Speaker: James Simon, MD, CCD, NCMP, FACOG, IF (USA)
01:40 p.m. - 01:50 p.m.
Effects of Systemic Treatment With Testosterone in Women With Sexual Dysfunction: An Observational Pilot Study (#025)
Speaker: Elisa Maseroli, MD (Italy)
01:50 p.m. - 02:00 p.m.
A Rapid, High-volume, See-and-treat Cervical Cancer Screening Program using Self-sampling, HPV PCR Testing, and Digital Colposcopy in Inner Mongolia (#026)
Speaker: Sarah Bedell (USA)
02:00 p.m. - 02:10 p.m.
Plasma Cell Mucositis of the Vagina and Cervix (#027)
Speaker: Leia Mitchell (USA)
02:10 p.m. - 02:20 p.m.
Impact of Vaginal Prasterone on the Frequency of Urinary Tract Infections (#028)
Speaker: Rachel Rubin, MD, IF (USA)
02:20 p.m. - 02:30 p.m.
Gender Intracrinology: The Vagina as an Androgen Target and Synthesis Organ (#029)
Speaker: Elisa Maseroli, MD (Italy)
02:30 p.m. - 02:40 p.m.
A Randomized, Active Placebo-controlled Trial of an Online Expressive Writing Intervention for the Sexual Well-being of Women with Childhood Sexual Abuse histories (#030)
Speaker: Chelsea Kilimnik (USA)
02:30 p.m. - 03:00 p.m.
Location: Canaveral
Coffee Break
03:00 p.m. - 03:30 p.m.
Location: Peninsula 4
NAMS Lecture
Moderator: Alyse Kelly-Jones, MD, IF, FACOG (USA)
Sex, Drugs and Rock And Roll
Speaker: Sheryl Kingsberg, PhD, IF (USA)
03:30 p.m. - 05:00 p.m.
Location: Peninsula 4
Symposium 4 - Hormonal Contraception: More Than You Bargained For?
Moderators: William Fisher, PhD (Canada) & Sue Goldstein, BA, CCRC, AASECT-CSE, IF (USA)
03:30 p.m. - 04:00 p.m.
Biologic Effects of Hormonal Contraceptives (ESSM Position Statement)
Speaker: Linda Vignozzi, MD (Italy)
04:00 p.m. - 04:30 p.m.
Psychosexual Effects of Hormonal Contraceptives (ESSM Position Statement)
Speaker: Michal Lew-Starowicz, MD, PhD (Poland)
04:30 p.m. - 05:00 p.m.
Risk Behaviors Related to Contraception
Speaker: William Fisher, PhD (Canada)
05:00 p.m. - 05:30 p.m.
Location: Peninsula 4
IUGA Lecture
Moderator: Juliana Kling, MD, MPH, NCMP, FACP (USA)
Sexual Function after Pelvic Floor Surgery: Pitfalls and Pearls
Speaker: Sylvia Botros-Brey, MD (USA)
Evening
05:30 p.m. - 07:00 p.m.
Location: Biscayne
Poster Session (with drinks and food)
Knowledge and Perception of Sexual Health Among Saudi Population (#040)
Speaker: Hasan Alkhudairi (Saudi Arabia)
Preliminary Report of a Novel Therapy for Chronic Pelvic Pain: SoLá Therapy (#041)
Speaker: Charles Butrick (USA)
Breast Cancer Patients in a Female Sexual Medicine and Women’s Health Program: A Cross-sectional Retrospective Study
(#042)
Speaker: Jeanne Carter (USA)
Different Forms of Mental Health Treatments are Associated with Different Patterns of Posttrauma Sexual Functioning in Women: An Exploratory Study (#043)
Speaker: Kirstin Clephane (USA)
Sexual and Emotional Affairs: Does Friendship Matter? (#044)
Speaker: Courtney Crosby (USA)
Sexual Disgust and Sexual Satisfaction (#045)
Speaker: Courtney Crosby (USA)
Feasibility, Acceptability and Effects of Physical Therapy Treatment for Gynecological Cancer Survivors with Dyspareunia (#046)
Speaker: Marie-Pierre Cyr (Canada)
Sexual Health and Cancer: An Awkward Silence (#047)
Speaker: Shilpa Gajarawala (USA)
Evaluation of Common Sexual Dysfunctions and Treatment Outcome in a Canadian Sexual Medicine Practice (#048)
Speaker: Rawan Gari (Saudi Arabia)
A Double-Blind, Sham Controlled Prospective Pilot Study of Urinary Stress Incontinence and Sexual Function in Women After 6 Treatments with HIFEM Technology (Emsella): Interim Analysis (#049)
Speaker: Irwin Goldstein, MD, IF (USA)
The Effects of Radiofrequency on Female Sexual Health (#050)
Speaker: Troy Hailparn (USA)
Effectiveness of App Based Intervention for the Treatment of Female Sexual Dysfunction (#051)
Speaker: Lyndsey Harper (USA)
Undergraduates' Definitions of Sexual Consent: The Role of Rape Myth Acceptance (#052)
Speaker: Sabira Ahmed (USA)
Proper Assessment for Cosmeto-gynecological Interventions: The Need to Evaluate the Relationship Discord, Body Dysmorphic Syndrome, and the Correct Energy-Based Technology (#053)
Speaker: Michael Krychman (USA)
Topical Alpha-1 Adrenergic Receptor Agonist Applied to the Nipple Areola Complex Significantly Improves Female Orgasmic Function (#054)
Speaker: Michael Krychman (USA)
A New Medical Device to Assist in the Treatment of Collison Dyspareunia: Results from the Soft Launch of Ohnut (#055)
Speaker: Michael Krychman (USA)
The Milli™; the Only Patient Controlled Expanding Dilator: Follow Up Survey Experience (#056)
Speaker: Michael Krychman (USA)
Rethinking the Techno Vagina: A Case Series of Patient Complications Following Vaginal Laser Treatment for Atrophy (#057)
Speaker: Michael Krychman (USA)
Genital Moisturizing Cosmetics: Do Not Forget the Vulva (#058)
Speaker: Michael Krychman (USA)
Speeding Assessment in Couples' Sex Therapy using an Online Self-assessment Tool (#059)
Speaker: Elizabeth Larson (USA)
Sexual Function Differences Among Female Marijuana Users with Sexual Dysfunction (#060)
Speaker: Becky K. Lynn, MD, IF (USA)
Including Sexuality in the Clinic Visit: Report of an Online Survey of a Sexuality Questionnaire in English and Spanish (#061)
Speaker: Lourdes Mantecon-Garza (USA)
ColorDoppler Ultrasound in the Evaluation of the Cardiometabolic Profile in Women With Sexual Dysfunction: A Gender Perspective (#062)
Speaker: Elisa Maseroli, MD (Italy)
Flibanserin: Enhanced Pharmacovigilance Study to Assess and Analyze the Risks of Adverse Events of Special Interest (#063)
Speaker: Leah Millheiser (USA)
Attitude of Women Nurse Practitioners for Embarrassing Female Sexual and Urinary Symptoms in Korea (#064)
Speaker: Kweonsik Min (Korea)
Vulvar Findings in GSM Patients Correlate with Severity of Overactive Bladder (#065)
Speaker: Noriko Ninomiya (Japan)
Pudendal Neuromodulation for Treatment of Female Orgasmic Disorder (#066)
Speaker: Elizabeth Olive (USA)
Number Needed to Harm for Treatments of Female Sexual Dysfunction (#067)
Speaker: Robert Pyke (USA)
Female Sexual Dysfunctions Associated With Male Premature Ejaculation (#068)
Speaker: Robert Pyke (USA)
Hormonal Contraceptive Use and Sexual Functioning among Young Women Who Experienced Sexual Victimization (#069)
Speaker: Anneliis Sartin-Tarm (USA)
Characteristics of Lubricants Sold in Pharmacies and Sex Shops in Capitals of 3 Brazilian States (#070)
Speaker: Ariel Gustavo Scafuri (Brasil)
Estradiol does not Increase with Low-dose Testosterone Replacement in Women after Menopause
(#071)
Speaker: Yuki Sekiguchi (Japan)
The Impact of Vaginal Dryness on Quality of Life and Work Productivity (#072)
Speaker: Temitayo Ogundimu (United Kingdom)
Characterization of Female Periurethral Glandular Tissue in the Periurethral Space Negatively Impacted by Mid-Urethral Sling Surgery (#073)
Speaker: Diane Tomalty (Canada)
MATE 2 Survey: Men’s Perspectives Toward Aging and Their Partner’s Menopause (#074)
Speaker: Sheryl Kingsberg, PhD, IF (USA)
Ease of Use of a Contraceptive Vaginal System (CVS), Containing Segesterone Acetate and Ethinyl Estradiol (SA/EE) (#075)
Speaker: Sheryl Kingsberg, PhD, IF (USA)
Growth of the Vulvar Vaginal Atrophy (VVA) Therapy Market (#076)
Speaker: Sheryl Kingsberg, PhD, IF (USA)
Postmenopausal Women Using a Softgel Estradiol Vaginal Insert to Treat Moderate to Severe Dyspareunia Were Satisfied With it and Preferred it Over a Previous Treatment (#077)
Speaker: Becky K. Lynn, MD, IF (USA)
Why Core Emotions Matter: Understanding Subcortical Affective Circuits as Key to Treatment of Sexual Disorders
(#078)
Speaker: Nan Wise (USA)
Evaluating the Performance of a Low-cost Mobile Phone Attachable Microscope in Cervical Cytology (#079)
Speaker: Ali Naqvi (USA)
Patient Reported Satisfaction Rating After Attending a Multidisciplinary Psychoeducational Sexual Wellness Program
(#080)
Speaker: Mary Lynn (USA)
Practice and Perception of Female Genital Mutilation in Women of Reproductive Age in North East Nigeria (#081)
Speaker: Raphael Attah (Nigeria)
Prevalence of Adenomyosis in Chronic Pelvic Pain Patients Undergoing Hysterectomy (#082)
Speaker: Nita Desai (USA)
The Effect of Ristela Supplementation on Female Sexual Function in Women Taking Antidepressants: An Open Label Trial (#083)
Speaker: Susan Kellogg-Spadt, PhD, CRNP, IF (USA)
Improvements in Female Sexual Function Index (FSFI) Domains Over Time after Flibanserin Treatment in Premenopausal Women with Hypoactive Sexual Desire Disorder (HSDD) (#084)
Speaker: Noel Kim, PhD, IF (USA)
Sunday, March 8, 2020
Morning
07:00 a.m. - 08:00 a.m.
Location: Peninsula 5-7
Meet the Expert Breakfast
Hormone Modulating Treatments for the Treatment of Androgen-mediated Cutaneous Disorders (AMCDs)
Speaker: Andrew Goldstein, MD, IF, FACOG (USA)
PGAD
Speaker: Irwin Goldstein, MD, IF (USA)
Recommending Sexual Devices and Aides: What's Best for Whom?
Speaker: Susan Kellogg-Spadt, PhD, CRNP, IF (USA)
The Vulva - How to See With Your Eyes Open and Identify Sources of Pain
Speaker: Alyse Kelly-Jones, MD, IF, FACOG (USA)
Treating GSM in Breast Cancer Patients
Speaker: Becky K. Lynn, MD, IF (USA)
Consensus Guidelines on the Use of Systemic Testosterone for Sexual Function in Women
Speaker: Sharon Parish, MD, IF, NCMP (USA)
Nonhormonal Treatment of Sexual Dysfunction in Menopausal Women
Speaker: James Simon, MD, CCD, NCMP, FACOG, IF (USA)
Care of the Transgender Patient in Your Practice
Speaker: Maureen Whelihan, MD, FACOG (USA)
08:00 a.m. - 09:30 a.m.
Location: Peninsula 4
Research Podium Session 4 - Education & Clinical Trials
Moderators: Stanley Althof, PhD, IF (USA) & Kristin Christiansen, MD (USA)
08:00 a.m. - 08:10 a.m.
Can We Give What We Don't Own: Self-objectification's Role in Sexual Consent Behaviors and Attitudes (#031)
Speaker: Allexa Zwinck (USA)
08:10 a.m. - 08:20 a.m.
A Novel Pathway for the Increased Inclusion of Sexual Health Education in Undergraduate Medical Education (#032)
Speaker: Elisabeth Gordon (USA)
08:20 a.m. - 08:30 a.m.
Evidence Not Rhetoric - A Sexual Health Elective Course for Medical Students (#033)
Speaker: Kari Stausmire (USA)
08:30 a.m. - 08:40 a.m.
The Contribution of the Cervix to the Female Sexual Response: Development of a Self-Reported Patient Survey (#034)
Speaker: Olivia Giovannetti (Canada)
08:40 a.m. - 08:50 a.m.
Patient Reported Outcomes of a Robotic-Assisted Double-Skin Flap Vaginoplasty Technique for Transfeminine Genital Reconstructive Surgery (#035)
Speaker: Jessica Schardein (USA)
08:50 a.m. - 09:00 a.m.
Two-Arm, Prospective, Open-Label, Pilot Study of Flibanserin versus Flibanserin and Sex Therapy in Pre- and Postmenopausal Women with HSDD (#036)
Speaker: Sue Goldstein, BA, CCRC, AASECT-CSE, IF (USA)
09:00 a.m. - 09:10 a.m.
Open-Label Pilot, Prospective Vulvoscopic Study of Daily Administration of Prasterone Vaginal Inserts in Women with Moderate to Severe Dyspareunia (#037)
Speaker: Sue Goldstein, BA, CCRC, AASECT-CSE, IF (USA)
09:10 a.m. - 09:20 a.m.
Effect Size of Bremelanotide Treatment in the Phase 3 RECONNECT Studies (#038)
Speaker: James Simon, MD, CCD, NCMP, FACOG, IF (USA)
09:20 a.m. - 09:30 a.m.
Effects of Sex Steroids on Relaxant/Contractile Pathways in Rat Vagina (#039)
Speaker: Linda Vignozzi, MD (Italy)
08:00 a.m. - 09:30 a.m.
Location: Peninsula 1-3
Instructional Course 4 - Sexual Health in Breast and Gynecologic Cancer Patients
Speakers: Don Dizon, MD (USA) & Mindy Goldman, MD (USA)